BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs2230926
,
MYC
,
Metabolism of xenobiotics
,
Obesity
,
Retina
,
Laryngoscope
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
peripheral cholinesterase inhibitor
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Adipose tissue
Vagina
Stomach cardiac
Myometrium
Mammary gland
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Gallbladder cancer
Poisoning by drug AND/OR medicinal substance
Toxic nephropathy
Eye / vision finding
Liver cancer
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
CCL2 protein, human
alpha 1-Antitrypsin
Dithiothreitol
Ascorbic Acid
kavain
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
e2f5
CTCFL
OTUD5
HCFC2
E2F4
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Glioblastoma stem-like cells with PDXP shRNA knockdown
Multiple cancer cell lines treated with 32 kinase inhibitors
L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for peripheral cholinesterase inhibitor
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected Patients
Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (…
A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)
Pharmacokinetics Centella Asiatica Product (CAP) in Mild Cognitive Impairment
The Effect of Intraperitoneal Bupivacaine Versus Bupivacaine With Neostigmine on Pain in Laparoscopi…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ